Andrews R. Robbins's most recent trade in Cogent Biosciences Inc was a trade of 840,000 Common Stock done . Disclosure was reported to the exchange on Dec. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 840,000 | 1,025,000 (3%) | 2% | 0 | Common Stock | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 367,497 | 657,503 (2%) | 1% | 39.5 | 14,497,757 | Common Stock |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 245,000 | 245,000 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 185,000 | 185,000 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 915,000 | 915,000 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 1,100,000 | 1,100,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Andrews R. Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 23,000 | 23,000 | - | - | Director Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Andrews R. Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 10,167 | 10,167 | - | - | Director Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 690,000 | 690,000 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 315,200 | 315,200 | - | - | Stock Option (Right to Buy) |